Mirtazapin Genericon (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising serotonin 5‑HT2 and 5‑HT3 receptors while strongly inhibiting H1 histamine receptors. This combined activity enhances noradrenergic and serotonergic neurotransmission and produces sedative and appetite‑stimulating effects that contribute to its antidepressant action.

The appropriate dose of Mirtazapin Genericon is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and tolerability. Dosage adjustments are made according to the prescriber’s judgment and local prescribing guidelines.

Safety data for mirtazapine in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers typically evaluate each case individually and may consider alternative treatments when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mirtazapine belongs to the NaSSA class, which differs from selective serotonin reuptake inhibitors (SSRIs) by its combined noradrenergic and serotonergic activity and strong antihistamine effect. Compared with SSRIs, it often causes more sedation and weight gain but may be preferred when patients need sleep improvement or have poor appetite.

Mirtazapin Genericon should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme humidity to maintain stability throughout its shelf life.

The medication is taken orally, usually as a tablet, and should be swallowed whole with a glass of water. It is commonly prescribed for once‑daily dosing, but the exact schedule is determined by the prescribing clinician.

Serious adverse events include agranulocytosis or severe neutropenia, hepatic dysfunction indicated by elevated liver enzymes, and the emergence or worsening of suicidal thoughts, particularly during the initial weeks of treatment. Prompt medical attention is required if any of these symptoms occur.

Mirtazapin Genericon is contraindicated in patients with known hypersensitivity to mirtazapine, those currently taking monoamine oxidase inhibitors (MAOIs) without an appropriate washout period, and individuals with severe hepatic impairment. Caution is also advised for patients with a history of bipolar disorder, as it may precipitate manic episodes.